biotech · Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · CUE
Cue Biopharma
Cue Biopharma is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker CUE. Primary therapeutic focus areas include Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal
Boston, USA HQ
2014 Founded
37 Employees
Public company Type
CUE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2014
- Employees
- 37
- Programs
- 5
- Drugs
- 0
- Patents
- 30
CUE-102
Phase 1 · mab · Recurrent Glioblastoma
CUE-102 for Recurrent Glioblastoma is a Phase 1 program (mab) at Cue Biopharma with 1 ClinicalTrials.gov record(s).
Internal code 25-023
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cue Biopharma
- Phase
- Phase 1
- Modality
- mab
- Indication
- Recurrent Glioblastoma
- Status
- active
- Trials
- 1